Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Multimodal preventive trials for Alzheimer’s Disease: towards multinational strategies

MIND-AD

The anticipated pandemic increase in the number of Alzheimer disease (AD) and dementia cases carries serious implications for society. The goal of the MIND-AD project is to identify effective prevention strategies for AD/dementia tailored to different at-risk groups. The project is based on experiences and data from five ongoing European...

Funding Programme
Start Date
End Date
Total Funding
€ 0
European Countries Involved

Multimodal tools for Molecular Imaging, Diagnostics and Therapeutics

MUMID

Non-invasive imaging techniques allow visualization of the dynamics and biochemical activity of pathological processes in real-time. By having proper molecular tools, a complete picture of pathologic conditions can be acquired at resolutions from the molecular level to the full body scale. Hence, smart multimodal imaging tools can be utilized for a...

Funding Programme
Start Date
End Date
Total Funding
€ 1 498 800
European Countries Involved

Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease

NPAD

This project aims at predicting early cognitive decline using a neurofeedback performance endophenotype based on realtime functional magnetic resonance imaging in a population at risk for Alzheimer’s Disease (AD). It has been proven that AD biomarkers change decades before the development of symptoms. In addition, there is a lack of robust...

Funding Programme
Start Date
End Date
Total Funding
€ 158 122
European Countries Involved

Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies

CHELALZ

This fellowship will provide a prolific researcher with an internationally competitive, multi-disciplinary research training at the Chemistry/Biology interface in an EU leading Bioinorganic chemistry team, preparing her to obtain her goal of a faculty position in the EU and her own research team in Medicinal Chemistry. She will develop novel anti...

Funding Programme
Start Date
End Date
Total Funding
€ 170 122
European Countries Involved

Music Interventions for Dementia and Depression in ELderly care (MIDDEL): International cluster-randomised trial

MIDDEL

Many older adults living in residential care homes suffer from dementia and depression. MIDDEL aims to determine if music interventions can help. Specifically, this trial will provide robust and generalisable results concerning the comparative effects of group music therapy (GMT), recreational choir singing (RCS), their combination, or standard...

Funding Programme
Start Date
End Date
Total Funding
€ 2 600 000
European Countries Involved

NAD+ International Scientist-training

NADIS

Nicotinamide adenine dinucleotide (NAD+) is a central redox cofactor and the limiting substrate of key metabolic enzymes. The constellation of cellular functions in which NAD+ is involved makes its availability critical for cell survival, and its depletion is a leading factor in a number of diseases in humans, ranging from rare inherited defects to...

Funding Programme
Start Date
End Date
Total Funding
€ 2 530 832
European Countries Involved

Nano-diamond tracers for MRI molecular imaging

NDI

Molecular imaging is the current standard of care for the diagnosis (staging) of cancer, the evaluation of cancer treatment effectiveness, and is generating evidence as the best predictor for earlier diagnosis of Alzheimer’s disease. Molecular imaging differs from traditional imaging in that probes known as biomarkers are used to help image...

Funding Programme
Start Date
End Date
Total Funding
€ 147 500
European Countries Involved

Nanocatalytic drugs towards Alzheimer's disease

ORGANOZYMES

Here is proposed nano-scale synthesis and combinatorial screening of medium sized peptide-transition metal catalyst libraries with the aim of producing libraries for screening highly selective catalysts for development of nano-medicines. The implementation of catalytic molecules as medicines is a new paradigm in treatment that can overcome a number...

Funding Programme
Start Date
End Date
Total Funding
€ 230 810
European Countries Involved

Nanofluidics for label-free detection of exosomes and protein aggregates in neurodegenerative disease research

EXO-CHIP

Microfluidics have become a powerful tool in biotechnology and life sciences, whereas the nanofluidic regime remains widely unused in industry and the clinical environment. Especially protein misfolding diseases such as Alzheimer’s, Parkinson’s and Huntington’s disease, recently experience a growing demand for single-molecule detection capabilities...

Funding Programme
Start Date
End Date
Total Funding
€ 210 911
European Countries Involved

NANOPARTICLES FOR THERAPY AND DIAGNOSIS OF ALZHEIMER DISEASE

NAD

The search for effective therapies and early detection strategies for Alzheimer’s Disease (AD), the major cause of dementia in Europe, is imperative. It is known that β-amyloid (Aβ) peptide plays a central role in neurodegeneration. In AD brain, Aβ is released in a soluble form that progressively becomes insoluble forming aggregates; extracellular...

Funding Programme
Start Date
End Date
Total Funding
€ 14 365 090

Nanoscale Analytical Methods to gain insight into the Initiation of Short-Term Memory

NAMISTMem

The aim of this project is to develop novel nano-bioanalytical methodologies to explore a molecular paradigm for the initiation of short-term memory (STM) based on exocytosis events. Despite the vital role in neural disorders such as Alzheimer’s disease, the molecular mechanisms of the initial step in STM formation is still mostly a mystery...

Funding Programme
Start Date
End Date
Total Funding
€ 185 857
European Countries Involved

Nanoscale organization and dynamics of ER-mitochondria contact sites upon induction of synaptic plasticity

SynERMCSs

The endoplasmic reticulum (ER) can rapidly reorganize its functional domains and inter-organelle communication sites in response to cellular demands. ER-mitochondria communication is essential for normal cell physiology, as it conveys lipid exchange, mitochondrial calcium uptake, among other vital processes for mitochondrial function. In neurons...

Funding Programme
Start Date
End Date
Total Funding
€ 206 887
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).